A002720 Stock Overview
Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Kukje Pharma Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩5,020.00 |
| 52 Week High | ₩8,120.00 |
| 52 Week Low | ₩3,530.00 |
| Beta | 0.66 |
| 1 Month Change | -20.94% |
| 3 Month Change | 1.52% |
| 1 Year Change | 8.66% |
| 3 Year Change | -27.94% |
| 5 Year Change | 12.40% |
| Change since IPO | 241.66% |
Recent News & Updates
Recent updates
Kukje Pharma Co., Ltd.'s (KRX:002720) Share Price Not Quite Adding Up
Mar 20
Kukje Pharma's (KRX:002720) Solid Profits Have Weak Fundamentals
Mar 20If You Had Bought Kukje Pharma (KRX:002720) Stock A Year Ago, You Could Pocket A 121% Gain Today
Mar 19These 4 Measures Indicate That Kukje Pharma (KRX:002720) Is Using Debt Reasonably Well
Feb 21What Type Of Shareholders Own The Most Number of Kukje Pharma Co., Ltd. (KRX:002720) Shares?
Jan 25
Kukje Pharma Co., Ltd.'s (KRX:002720) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Dec 30Investors Who Bought Kukje Pharma (KRX:002720) Shares Five Years Ago Are Now Up 227%
Dec 04Shareholder Returns
| A002720 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 0.5% | 5.5% | 3.4% |
| 1Y | 8.7% | 8.1% | 7.1% |
Return vs Industry: A002720 matched the KR Pharmaceuticals industry which returned 8.1% over the past year.
Return vs Market: A002720 exceeded the KR Market which returned 7.1% over the past year.
Price Volatility
| A002720 volatility | |
|---|---|
| A002720 Average Weekly Movement | 11.0% |
| Pharmaceuticals Industry Average Movement | 4.6% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A002720's share price has been volatile over the past 3 months.
Volatility Over Time: A002720's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1959 | 259 | Tae-hoon Nam | www.kukjepharm.co.kr |
Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other antibiotics, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAIDS and other analgesics, gastrointestinal and cardiovascular agents, antidiabetics, genitourinary and respiratory agents, other ETC products, and other products.
Kukje Pharma Co., Ltd. Fundamentals Summary
| A002720 fundamental statistics | |
|---|---|
| Market cap | ₩102.68b |
| Earnings (TTM) | -₩8.42b |
| Revenue (TTM) | ₩135.37b |
0.8x
P/S Ratio-12.1x
P/E RatioIs A002720 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A002720 income statement (TTM) | |
|---|---|
| Revenue | ₩135.37b |
| Cost of Revenue | ₩68.15b |
| Gross Profit | ₩67.22b |
| Other Expenses | ₩75.64b |
| Earnings | -₩8.42b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -415.53 |
| Gross Margin | 49.66% |
| Net Profit Margin | -6.22% |
| Debt/Equity Ratio | 35.3% |
How did A002720 perform over the long term?
See historical performance and comparison